Streetbeat News

Analyst Ratings

SJW

B of A Securities has initiated coverage on SJW Group with a Neutral rating and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:48 am

THO

Thor Industries is set to release its Q4 earnings on Sept. 24, with expectations of $4.83 EPS and $21.99 billion in revenue. Analysts have adjusted their ratings and price targets, with some maintaining positive outlooks despite price target reductions.

Portfolio Pulse from Avi Kapoor

September 20, 2024 | 11:44 am

NKE

Deutsche Bank analyst Krisztina Katai maintains a Buy rating on Nike with a $92 price target.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:32 am

NKE

Baird analyst Jonathan Komp maintains an Outperform rating on Nike and raises the price target from $100 to $110.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:31 am

MEDP

Baird analyst Eric Coldwell maintains an Outperform rating on Medpace Holdings (NASDAQ:MEDP) but lowers the price target from $430 to $413.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:23 am

LH

Baird analyst Eric Coldwell maintains an Outperform rating on Labcorp Holdings and raises the price target from $278 to $282.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:20 am

IQV

Baird analyst Eric Coldwell maintains a Neutral rating on IQVIA Holdings (NYSE:IQV) and raises the price target from $251 to $256.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:16 am

ICLR

Baird analyst Eric Coldwell maintains an Outperform rating on Icon (NASDAQ:ICLR) but lowers the price target from $368 to $340.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:11 am

CRL

Baird analyst Eric Coldwell maintains a Neutral rating on Charles River (NYSE:CRL) and slightly lowers the price target from $191 to $190.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:08 am

AHR

Keybanc analyst Austin Wurschmidt has maintained an Overweight rating on American Healthcares (NYSE:AHR) and raised the price target from $27 to $28.

Portfolio Pulse from Benzinga Newsdesk

September 20, 2024 | 11:07 am